You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

46 search results for: biologics

EAACI 2023 | Pediatric Severe Asthma: Why Lung Function Matters
expert video

EAACI 2023 | Pediatric Severe Asthma: Why Lung Function Matters

Pulmonology
Join Prof. Monika Gappa and Dr. Leonard Bacharier as they explore the importance of lung function in pediatric asthma disease progression
View more
The Potential Impact of Early Intervention in Atopic Dermatitis in Children
expert video

The Potential Impact of Early Intervention in Atopic Dermatitis in Children

Dermatology
Dr. Amy Paller shares her opinion of whether treatment is needed when children might outgrow their disease.
View more
Can Chronic Rhinosinusitis With Nasal Polyps be Considered in Remission if the Patient has an Impaired Sense of Smell?
expert video

Can Chronic Rhinosinusitis With Nasal Polyps be Considered in Remission if the Patient has an Impaired Sense of Smell?

Rhinology
Dr. Backer discusses assessing remission in CRSwNP by evaluating the patient's sense of smell in this video clip from the EAACI 2024 symposium.
View more
ERS 2023 | Adult Asthma Symposium: Mini Debate
expert video

ERS 2023 | Adult Asthma Symposium: Mini Debate

Pulmonology
Prof. Ian Pavord moderates a debate between Prof. Vibeke Backer and Dr. Francesca Puggioni about what a patient's lung function should be in order to be defined as achieving clinical remission in adult asthma.
View more
ERS 2023 | Adult Asthma Symposium: Panel Discussion
expert video

ERS 2023 | Adult Asthma Symposium: Panel Discussion

Pulmonology
Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni and audience members share their views on the proposed framework for clinical remission in severe asthma.
View more
ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​
expert video

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

Pulmonology
Join Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni for an educational program on the topic of clinical remission in severe asthma.
View more
When is the right time to consider a biologic in patients with CRSwNP?
expert video

When is the right time to consider a biologic in patients with CRSwNP?

Rhinology
Prof. Hellings and Prof. Corso explain that the right time to implement a biologic depends on academic and reimbursement criteria, which vary by country.
View more
What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?
expert video

What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?

Rhinology
Prof. Hellings and Prof. Corso highlight that disease severity plays a key role in rate and control of remission in CRS.
View more
GINA Asthma Decision Tree
videoanimation

GINA Asthma Decision Tree

Pulmonology
Walk through the GINA decision tree for severe asthma
View more
Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?
expert video

Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?

Rhinology
Prof. Hellings and Prof. Corso discuss the significance and rationale behind the new definition of CRSwNP.
View more
Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?
expert video

Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?

Pulmonology
Prof. Monika Gappa presents the importance in assessment of lung function in pediatric patients alongside the associated patient burden.
View more
Navigating Recent Scientific Advances in Atopic Dermatitis: Skin Barrier Dysfunction, Dysbiosis, and Itch
expert video

Navigating Recent Scientific Advances in Atopic Dermatitis: Skin Barrier Dysfunction, Dysbiosis, and Itch

Dermatology
Experts discuss the latest evidence on how type 2 inflammation drives skin barrier dysfunction, affects the skin microbiome, and contributes to neuroimmune dysregulation in AD.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: MalaysiaChange country/region